CEL-SCI Corp
AMEX:CVM
CEL-SCI Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.1
38.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does CEL-SCI Corp hold over its rivals?
What risks and challenges
does CEL-SCI Corp face in the near future?
Provide an overview of the primary business activities
of CEL-SCI Corp.
Show me price targets
for CEL-SCI Corp made by professional analysts.
Provide an overview of the primary business activities
of CEL-SCI Corp.
What unique competitive advantages
does CEL-SCI Corp hold over its rivals?
What risks and challenges
does CEL-SCI Corp face in the near future?
Has there been any significant insider trading activity
in CEL-SCI Corp recently?
Show all valuation multiples
for CEL-SCI Corp.
Provide P/S
for CEL-SCI Corp.
Provide P/E
for CEL-SCI Corp.
Provide P/OCF
for CEL-SCI Corp.
Provide P/FCFE
for CEL-SCI Corp.
Provide P/B
for CEL-SCI Corp.
Provide EV/S
for CEL-SCI Corp.
Provide EV/GP
for CEL-SCI Corp.
Provide EV/EBITDA
for CEL-SCI Corp.
Provide EV/EBIT
for CEL-SCI Corp.
Provide EV/OCF
for CEL-SCI Corp.
Provide EV/FCFF
for CEL-SCI Corp.
Provide EV/IC
for CEL-SCI Corp.
Show me price targets
for CEL-SCI Corp made by professional analysts.
What are the Revenue projections
for CEL-SCI Corp?
How accurate were the past Revenue estimates
for CEL-SCI Corp?
What are the Net Income projections
for CEL-SCI Corp?
How accurate were the past Net Income estimates
for CEL-SCI Corp?
What are the EPS projections
for CEL-SCI Corp?
How accurate were the past EPS estimates
for CEL-SCI Corp?
What are the EBIT projections
for CEL-SCI Corp?
How accurate were the past EBIT estimates
for CEL-SCI Corp?
Compare the revenue forecasts
for CEL-SCI Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of CEL-SCI Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of CEL-SCI Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of CEL-SCI Corp compared to its peers.
Compare the P/E ratios
of CEL-SCI Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing CEL-SCI Corp with its peers.
Analyze the financial leverage
of CEL-SCI Corp compared to its main competitors.
Show all profitability ratios
for CEL-SCI Corp.
Provide ROE
for CEL-SCI Corp.
Provide ROA
for CEL-SCI Corp.
Provide ROIC
for CEL-SCI Corp.
Provide ROCE
for CEL-SCI Corp.
Provide Gross Margin
for CEL-SCI Corp.
Provide Operating Margin
for CEL-SCI Corp.
Provide Net Margin
for CEL-SCI Corp.
Provide FCF Margin
for CEL-SCI Corp.
Show all solvency ratios
for CEL-SCI Corp.
Provide D/E Ratio
for CEL-SCI Corp.
Provide D/A Ratio
for CEL-SCI Corp.
Provide Interest Coverage Ratio
for CEL-SCI Corp.
Provide Altman Z-Score Ratio
for CEL-SCI Corp.
Provide Quick Ratio
for CEL-SCI Corp.
Provide Current Ratio
for CEL-SCI Corp.
Provide Cash Ratio
for CEL-SCI Corp.
What is the historical Revenue growth
over the last 5 years for CEL-SCI Corp?
What is the historical Net Income growth
over the last 5 years for CEL-SCI Corp?
What is the current Free Cash Flow
of CEL-SCI Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for CEL-SCI Corp.
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
C
|
CEL-SCI Corp
AMEX:CVM
|
42m USD | 0 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 0 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
344.8B USD | 10 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
325.9B USD | 410 219.3 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
159.6B USD | 9.4 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
140.9B USD | 6.9 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.9B USD | 11.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 687 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
127.9B AUD | 11.4 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.5B USD | 4.5 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
51.9B USD | 24.9 |
|
US |
C
|
CEL-SCI Corp
AMEX:CVM
|
Average EV/GP:
45 887.2
|
|
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Not Available |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
10
|
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
410 219.3
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
9.4
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
6.9
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.8
|
|
US |
E
|
Epizyme Inc
F:EPE
|
2 687
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
11.4
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
4.5
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
24.9
|
|
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.